Symptomatic endocrine abnormalities in malignant disease may arise either from deficiency states or from the inappropriate or ectopic secretion of a hormone. The clinical picture of the commoner syndromes is described in this review, together with the surgical or medical palliation which may assist the patient.
Pearse AGThe diffuse neuroendocrine system and the APUD concept: related 'endocrine' peptides in brain, intestine, pituitary, placenta and anuran cutaneous glands . Med Biol1977; 55: 115.
2.
Besterman HSHypopituitorism. In: Jung RT, Sikora K eds, Endocrine problems in cancer . London: Heinemann Medical Books Ltd, 1984: 137-66.
3.
NugentJLBunn PA, Matthews MJ et al. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer1979; 44: 1885-93.
4.
Heath DAHypercalcaemia of malignancy. Palliative Medicine1989; 3: 1-11.
5.
Carey RM, Varma SK, Drake CR, Sr et al. Ectopic secretion of corticotrophin-releasing factor as a cause of Cushing's syndrome. N Engl J Med1984; 311: 13-30.
6.
Howlett TA, Drury PL, Perry L., Doniach I., Rees LH, Besser GMDiagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol1986; 24: 699-713.
7.
Bondy PK, Gilby EDEndocrine functions in small cell undifferentiated carcinoma of the lung. Cancer1982; 50: 2147-53.
8.
Ratter SJ, Lowry PJ, Besser GM, Rees LHChromatographic characteristics of adrenocorticotrophin in human plasma. J Endocrinol1980; 85: 359-69.
9.
Hale AC, Besser GM, Rees LHCharacterisation of pro-opiomelanocortin derived peptides in pituitary and ectopic adrenocorticotrophin-secreting tumours. J Endocrinol1986; 108: 49-56.
10.
Pullman PT, Clement-Jones V., Corder R. et al. Ectopic production of methionine enkephalin and B-endorphin . Br MedJ1980; 280: 758-59.
Howlett TA, Price J., Hale AC et al. Pituitary ACTH dependent Cushing's syndrome due to ectopic production of a bombesin-like peptide by a medullary carcinoma of the thyroid. Clin Endocrinol1985; 22: 91-101.
13.
Hale AC, Price J., Ackland JF et al. Corticotrophin-releasing factor mediated adrenocorticotrophin release from rat anterior pituitary cells is potentiated by c-terminal gastrin-releasing peptide. J Endocrinol1984; 102: R1-R3 .
Silverberg J., O'Donnell J., Sugenoya A., Row VV, Volpe R.Effect of human chorionic gonadotrophin on human thyroid tissue. J Clin Endocrinol Metab1978; 46: 420-24.
16.
Thorner MO, Perryman RL, Cronin MJ et al. Somatotroph hyperplasia successful treatment of acromegaly by removal of a pancreatic islet tumour secreting a growth hormone-releasing factor. J Clin Invest1982; 70: 965-77.
17.
Dowsett M., McGarrick GE, Harris AL, Coombes RC, Smith IE, Jeffcoate SLPrognostic significance of serum prolactin levels in advanced breast cancer . Br J Cancer1983; 47: 763-69.
18.
Noel GH, Suk HK, Stone JG, Frantz AGHuman prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab1972; 35: 840-51.
19.
Turkington RWEctopic production of prolactin. N Engl J Med1981; 285: 1455-58.
20.
Bartter FC, Schwartz WBThe syndrome of inappropriate secretion of antidiuretic hormone. Am J Med1967; 42: 790-806.
21.
de Troyer A. , Demanet JCClinical, biological and pathogenic features of the syndrome of inappropriate secretion of antidiuretic hormone. Q J Med1976; 45: 521-31.
22.
Robertson GLCancer and inappropriate diuresis. In: RW Ruddin. Biological markers of neoplasia - basic and applied aspects. New York : Elsevier, 1978.
Verner JV, Morrison ABIslet cell tumour and a syndrome of refractory watery diarrhea and hypokalaemia . Am J Med1958; 25: 374-80.
25.
O'Neal LW, Kipnis DM, Luse SA, Lacy, PE, Jarrett L.Secretion of various endocrine substances by ACTH-secreting tumors- gastrin, melanotrophin, norepinephrine, serotonin, parathormone, vasopressin, glucagon . Cancer1968; 21: 1219-32.
26.
Wynick D., Williams SJ, Bloom SRSymptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors. N Engl J Med1988; 319: 605-607.
27.
Ch'ng Jlc, Anderson JV, Williams SJ, Carr, DH, Bloom SRRemission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue. Br Med J1986; 292: 981-82.
28.
Anderson JV , Bloom SRNeuroendocrine tumours of the gut: long term therapy with the somatostatin analogue SMS 201-995. ScandJ Gastroenterol1986; suppl 119: 115-28.
Skrabanek P., Powell D.Ectopic insulin and Occam's razor: reappraisal of the riddle of tumour hypoglycaemia . Clin Endocrinol1978; 9: 141-54.
31.
Daughaday WH, Trivedi B., Kapadia M.Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion and patients with tumor-associated hypoglycaemia. J Clin Endocrinol Metab1981; 53: 289-94.
32.
Daughaday WH , Emanuelle MA, Brooks MH, Barbato AL, Kapadia M., Rotwein P.Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycaemia. N EnglJ Med1988; 319: 1441-46.
33.
Zapf J., Walter H., Froesch ERRadioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycaemia. J Clin Invest1981; 68: 1321-30.
